Consult Super-Specialist Doctors at CARE Hospitals
Chikungunya is a viral disease borne by the Aedes mosquito, which is spread through mosquito bites or via organ transplants. There may also be congenital transmission of the chikungunya virus. Chikungunya infection is characterised by a sudden onset of high fever, severe joint pain, and fatigue. Diagnosis of chikungunya virus fever can be achieved through a serological chikungunya diagnostic test using a blood sample. Testing for the chikungunya virus can help detect and prevent its transmission.
The chikungunya diagnosis test is a simple serological test performed to diagnose or rule out chikungunya infection in a person who exhibits symptoms similar to those of a chikungunya infection, such as fever. The chikungunya fever test detects the presence of IgG and IgM antibodies in the blood sample, which may have been produced in response to an ongoing or past chikungunya infection. The presence of these antibodies in the patient's blood sample can assist doctors in diagnosing a current infection with the chikungunya virus.
The chikungunya diagnosis test may be recommended by a doctor who identifies symptoms of chikungunya infection during a patient's diagnosis. Chikungunya virus infection symptoms typically appear about a week after the infection. Common symptoms of chikungunya virus infection include:
The test for chikungunya virus requires a blood sample from the infected person, which is then tested using a semi-quantitative enzyme-linked immunosorbent assay (ELISA test). A phlebotomist performs the blood-drawing procedure, taking blood from a vein in the arm and collecting it using a sterile needle.
A doctor recommends the chikungunya blood test to diagnose chikungunya fever in patients. This test utilises enzyme-linked immunosorbent assay (ELISA) to detect the presence of IgG and IgM antibodies in the blood sample. Rapid chikungunya diagnostic blood tests can also assist in identifying and limiting the spread of the virus.
No preparations or fasting are required for the chikungunya fever test. However, doctors may recommend taking certain precautions that could affect the test results. These precautions may include the following:
The Chikungunya test is typically performed within 6 days of the onset of illness. The IgG and IgM antibody test results for the Chikungunya test are provided below for reference.
SI. No. |
Component |
Range |
Interpretation |
1. |
Chikungunya IgG antibody |
Between 0.80 and 1.09 |
May indicate the presence of anti-chikungunya antibodies, test should be repeated within 1-2 weeks. |
> 1.10 |
Definitively indicates the presence of anti-chikungunya antibodies, may be due to past or current infection. |
||
2. |
Chikungunya IgM antibody |
Between 0.80 and 1.09 |
Indicates possible presence of anti-chikungunya antibodies, test should be repeated within 1-2 weeks. |
> 1.10 |
Definitively indicates the presence of anti-chikungunya antibodies, suggests present or past infection. |
The chikungunya test procedure is a simple serological test that rarely causes complications or health side effects. However, there is a slight chance of certain risks, such as:
Chikungunya infection is easily transmissible and can quickly become a contagious epidemic. Prompt testing and screening for the chikungunya virus infection can help control its local spread. The IgG and IgM antibody tests can identify the chikungunya virus in a blood sample from an infected person.
Persons residing in regions with documented chikungunya outbreaks who exhibit symptoms of the infection may be advised to undergo the chikungunya testing procedure. Individuals who have recently travelled to areas with known chikungunya outbreaks may also require testing for the viral infection.
Chikungunya infection symptoms typically manifest 3-7 days after being bitten by an infected mosquito. Common chikungunya virus infection symptoms include:
A positive chikungunya test result may indicate a current or past infection with the virus. If active symptoms of chikungunya infection are present, a doctor may recommend appropriate treatment.
Currently, there is no vaccine available for the chikungunya virus in India.
Since there are no vaccines available for the chikungunya virus, it is important to take precautions to prevent infection. These precautions may include the following:
The incubation period for chikungunya virus infection is typically 3 to 7 days after transmission.